NCT00398125View on ClinicalTrials.gov

Monotherapy Versus Placebo Over 10 Days in Integrase Naive HIV-1 Infected Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2006

Study Completion Date

April 30, 2007

Conditions
Infection, Human Immunodeficiency VirusHIV-1 Infection
Interventions
DRUG

GSK364735

Trial Locations (12)

20007

GSK Investigational Site, Washington D.C.

30308

GSK Investigational Site, Atlanta

32803

GSK Investigational Site, Orlando

33020

GSK Investigational Site, Hollywood

33308

GSK Investigational Site, Fort Lauderdale

35294

GSK Investigational Site, Birmingham

75246

GSK Investigational Site, Dallas

80220

GSK Investigational Site, Denver

90048

GSK Investigational Site, Los Angeles

92103

GSK Investigational Site, San Diego

94115

GSK Investigational Site, San Francisco

07102

GSK Investigational Site, Newark

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY